PL2573568T3 - Próba rozróżniająca - Google Patents

Próba rozróżniająca

Info

Publication number
PL2573568T3
PL2573568T3 PL12196714T PL12196714T PL2573568T3 PL 2573568 T3 PL2573568 T3 PL 2573568T3 PL 12196714 T PL12196714 T PL 12196714T PL 12196714 T PL12196714 T PL 12196714T PL 2573568 T3 PL2573568 T3 PL 2573568T3
Authority
PL
Poland
Prior art keywords
distinguishing assay
distinguishing
assay
Prior art date
Application number
PL12196714T
Other languages
English (en)
Inventor
Kay-Gunnar Stubenrauch
Markus Zadak
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PL2573568T3 publication Critical patent/PL2573568T3/pl

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL12196714T 2007-12-15 2008-12-12 Próba rozróżniająca PL2573568T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP07024353 2007-12-15
EP08002450 2008-02-11
EP12196714.5A EP2573568B1 (en) 2007-12-15 2008-12-12 Distinguishing assay
EP08862356A EP2223118B1 (en) 2007-12-15 2008-12-12 Distinguishing assay

Publications (1)

Publication Number Publication Date
PL2573568T3 true PL2573568T3 (pl) 2015-05-29

Family

ID=40339911

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12196714T PL2573568T3 (pl) 2007-12-15 2008-12-12 Próba rozróżniająca

Country Status (15)

Country Link
US (2) US8227195B2 (pl)
EP (2) EP2573568B1 (pl)
JP (2) JP5221673B2 (pl)
KR (1) KR101187627B1 (pl)
CN (2) CN103399145B (pl)
AU (1) AU2008337904B2 (pl)
BR (1) BRPI0821267A2 (pl)
CA (1) CA2709127C (pl)
DK (1) DK2573568T3 (pl)
ES (2) ES2532483T3 (pl)
IL (2) IL205206A (pl)
MX (1) MX2010005891A (pl)
PL (1) PL2573568T3 (pl)
SI (1) SI2573568T1 (pl)
WO (1) WO2009077127A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2322216A1 (en) 1997-03-21 2011-05-18 Chugai Seiyaku Kabushiki Kaisha A preventive or therapeutic agent for sensitized T cell-mediated diseases comprising IL-6 antagonist as an active ingredient
UA80091C2 (en) 2001-04-02 2007-08-27 Chugai Pharmaceutical Co Ltd Remedies for infant chronic arthritis-relating diseases and still's disease which contain an interleukin-6 (il-6) antagonist
CN101721362B (zh) * 2002-02-14 2018-07-03 中外制药株式会社 包含抗体的溶液制剂
GB2401040A (en) 2003-04-28 2004-11-03 Chugai Pharmaceutical Co Ltd Method for treating interleukin-6 related diseases
WO2005090405A1 (ja) * 2004-03-24 2005-09-29 Chugai Seiyaku Kabushiki Kaisha インターロイキン-6受容体に対するヒト型化抗体のサブタイプ
JP4902674B2 (ja) * 2006-03-09 2012-03-21 エフ.ホフマン−ラ ロシュ アーゲー 抗薬物抗体アッセイ法
PE20091174A1 (es) 2007-12-27 2009-08-03 Chugai Pharmaceutical Co Ltd Formulacion liquida con contenido de alta concentracion de anticuerpo
SI2493922T1 (sl) 2009-10-26 2017-06-30 F. Hoffmann-La Roche Ag Postopek za proizvodnjo glikoziliranega imunoglobulina
EP2354792A1 (en) * 2010-02-08 2011-08-10 Biomonitor A/S Method for detecting anti-drug antibodies
KR20130100908A (ko) * 2010-04-29 2013-09-12 떼라디아 에스아 항체 검출 방법
KR20190120439A (ko) 2010-11-08 2019-10-23 제넨테크, 인크. 피하 투여용 항―il―6 수용체 항체
BR112015032960B1 (pt) * 2013-07-04 2021-01-05 F. Hoffmann-La Roche Ag imunoensaio suprimido por interferência para detectar anticorpos anti-fármaco em amostras de soro
DK3084439T3 (en) * 2013-12-20 2018-12-03 Phadia Ab ANALYSIS OF ANTIBODIES
MX2017005156A (es) * 2014-11-05 2017-08-08 Hoffmann La Roche Metodo para determinacion de anticuerpos de anti-farmaco contra anticuerpo de farmaco humano o humanizado de funcion efectora suprimida.
WO2017147169A1 (en) 2016-02-22 2017-08-31 Ohio State Innovation Foundation Chemoprevention using controlled-release formulations of anti-interleukin 6 agents, synthetic vitamin a analogues or metabolites, and estradiol metabolites
CN110603057A (zh) 2017-03-17 2019-12-20 俄亥俄州创新基金会 用于递送化学预防剂的纳米颗粒
CN114910635B (zh) * 2017-10-26 2025-05-02 科美诊断技术股份有限公司 一种无基质效应的均相免疫检测试剂盒及其应用
EP3947737A2 (en) 2019-04-02 2022-02-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting and preventing cancer in patients having premalignant lesions
KR102583329B1 (ko) * 2020-11-12 2023-09-27 바디텍메드(주) 자성 입자 기반 약물 또는 약물 항체 검출 방법
JP7062803B1 (ja) 2021-03-31 2022-05-06 積水メディカル株式会社 抗薬物抗体測定方法
WO2025224166A1 (en) * 2024-04-23 2025-10-30 F. Hoffmann-La Roche Ag Anti-drug antibody assays

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
WO1987002778A1 (en) 1985-10-22 1987-05-07 Cooper-Lipotech Solid-phase liposome immunoassay system
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
ZA898290B (en) 1988-11-03 1991-06-26 Igen Inc Electrochemiluminescent assays
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
JPH04507285A (ja) 1988-12-09 1992-12-17 セントコー・インコーポレーテッド 抗イディオトープ免疫検定法
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
US5614191A (en) 1995-03-15 1997-03-25 The United States Of America As Represented By The Department Of Health And Human Services IL-13 receptor specific chimeric proteins and uses thereof
US6015681A (en) * 1995-07-28 2000-01-18 The United States Of America As Represented By The Secretary Of The Navy Rapid immunoassay for cariogenic bacteria
JP4224135B2 (ja) 1995-10-23 2009-02-12 ズィナイス セラピューティックス ピーティーワイ.エルティーディー. 新規なヘモポエチン受容体およびそれをコードする遺伝子配列
DE19649390A1 (de) * 1996-11-29 1998-06-04 Boehringer Mannheim Gmbh Antigenspezifischer IgG-Nachweis
AU5874798A (en) 1997-01-31 1998-08-25 Biovation Limited Vaccination methods and molecules
EP0983303B1 (en) 1997-05-21 2006-03-08 Biovation Limited Method for the production of non-immunogenic proteins
AU776910B2 (en) 1998-12-08 2004-09-23 Merck Patent Gesellschaft Mit Beschrankter Haftung Modifying protein immunogenicity
CA2480059C (en) 2002-03-22 2015-11-24 Amrad Operations Pty. Ltd. Monoclonal antibody against interleukin-13 receptor alpha 1 (il-13r.alpha.1)
US7211396B2 (en) * 2002-04-18 2007-05-01 Antibodyshop A/S Antibody pairs and kits for immunochemical determination of mannan-binding lectin
US20060239927A1 (en) 2003-03-31 2006-10-26 Kyowa Hakko Kogyo Co., Drug for airway administration
ES2383014T3 (es) 2003-04-02 2012-06-15 F. Hoffmann-La Roche Ag Anticuerpos contra el factor I de crecimiento similar a insulina y usos de los mismos
AR046071A1 (es) 2003-07-10 2005-11-23 Hoffmann La Roche Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos
CA2543830A1 (en) 2003-10-27 2005-05-19 Monogram Biosciences, Inc. Detecting human anti-therapeutic antibodies
TWI306862B (en) 2005-01-03 2009-03-01 Hoffmann La Roche Antibodies against il-13 receptor alpha 1 and uses thereof
DK2645106T4 (da) * 2005-04-04 2024-12-02 Biogen Ma Inc Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel
JP4902674B2 (ja) * 2006-03-09 2012-03-21 エフ.ホフマン−ラ ロシュ アーゲー 抗薬物抗体アッセイ法
CN101074958A (zh) * 2006-05-17 2007-11-21 上海森雄科技实业有限公司 一种层粘连蛋白诊断试剂盒

Also Published As

Publication number Publication date
HK1189937A1 (en) 2014-06-20
MX2010005891A (es) 2010-06-09
JP2012112972A (ja) 2012-06-14
KR20100077056A (ko) 2010-07-06
SI2573568T1 (sl) 2015-05-29
CA2709127A1 (en) 2009-06-25
CN103399145B (zh) 2015-06-24
IL205206A (en) 2014-04-30
KR101187627B1 (ko) 2012-10-09
AU2008337904A1 (en) 2009-06-25
ES2407603T3 (es) 2013-06-13
US8530176B2 (en) 2013-09-10
IL220024A (en) 2014-04-30
JP5782644B2 (ja) 2015-09-24
US20120219974A1 (en) 2012-08-30
US8227195B2 (en) 2012-07-24
JP2011506943A (ja) 2011-03-03
WO2009077127A1 (en) 2009-06-25
EP2573568B1 (en) 2015-01-14
DK2573568T3 (en) 2015-02-09
CA2709127C (en) 2013-11-12
EP2223118A1 (en) 2010-09-01
JP5221673B2 (ja) 2013-06-26
IL220024A0 (en) 2012-06-28
CN101896820A (zh) 2010-11-24
BRPI0821267A2 (pt) 2015-06-16
US20100304400A1 (en) 2010-12-02
EP2573568A1 (en) 2013-03-27
EP2223118B1 (en) 2013-02-27
ES2532483T3 (es) 2015-03-27
AU2008337904B2 (en) 2014-02-13
IL205206A0 (en) 2010-12-30
CN103399145A (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
IL220024A0 (en) Distinguishing assay
GB0717043D0 (en) Assay device
GB201006435D0 (en) Assay device
GB0713930D0 (en) Novel assay methods
GB0706906D0 (en) Assay device
GB0807534D0 (en) Assay
GB0811567D0 (en) Assay
GB0809262D0 (en) Assay
GB0803850D0 (en) Assay
GB0811858D0 (en) Assay
GB0718606D0 (en) Multiparameter assay
GB0814591D0 (en) Assay
GB0822260D0 (en) Assay
GB0608446D0 (en) Assay
GB0600031D0 (en) Assay
GB0822010D0 (en) Assay
GB0821624D0 (en) Assay
GB0615813D0 (en) Assay
GB0607462D0 (en) Assay
GB0623892D0 (en) Assay
GB0721944D0 (en) Assay
GB0711955D0 (en) Assay
GB0715386D0 (en) Assay
GB0719757D0 (en) Assay
GB0715725D0 (en) Assay